Edap TMS SA (EDAP)
2.69
-0.17
(-5.94%)
USD |
NASDAQ |
Nov 04, 16:00
2.72
+0.03
(+1.12%)
After-Hours: 20:00
Edap TMS Profit Margin (Quarterly): -38.83% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -38.83% |
March 31, 2024 | -30.50% |
December 31, 2023 | -25.71% |
September 30, 2023 | -33.62% |
June 30, 2023 | -32.90% |
March 31, 2023 | -50.63% |
December 31, 2022 | -32.64% |
September 30, 2022 | 0.11% |
June 30, 2022 | 12.89% |
March 31, 2022 | 2.77% |
December 31, 2021 | 9.77% |
September 30, 2021 | -10.75% |
June 30, 2021 | -4.10% |
March 31, 2021 | 7.50% |
December 31, 2020 | 5.08% |
September 30, 2020 | -10.61% |
June 30, 2020 | -1.89% |
March 31, 2020 | -17.19% |
December 31, 2019 | -8.16% |
September 30, 2019 | 7.60% |
June 30, 2019 | 11.04% |
March 31, 2019 | 3.24% |
December 31, 2018 | 15.61% |
September 30, 2018 | -5.29% |
June 30, 2018 | -8.92% |
Date | Value |
---|---|
March 31, 2018 | 0.97% |
December 31, 2017 | -0.86% |
September 30, 2017 | -7.37% |
June 30, 2017 | -18.74% |
March 31, 2017 | 19.38% |
December 31, 2016 | -11.95% |
September 30, 2016 | 15.78% |
June 30, 2016 | 30.47% |
March 31, 2016 | 15.58% |
December 31, 2015 | 43.39% |
September 30, 2015 | -75.39% |
June 30, 2015 | 6.21% |
March 31, 2015 | -39.25% |
December 31, 2014 | -40.72% |
September 30, 2014 | 94.79% |
June 30, 2014 | -93.48% |
March 31, 2014 | 10.82% |
December 31, 2013 | -7.05% |
September 30, 2013 | -6.70% |
June 30, 2013 | -4.33% |
March 31, 2013 | -65.51% |
December 31, 2012 | -11.65% |
September 30, 2012 | -8.74% |
June 30, 2012 | -48.72% |
March 31, 2012 | -59.88% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-50.63%
Minimum
Mar 2023
12.89%
Maximum
Jun 2022
-13.65%
Average
-10.61%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
DBV Technologies SA | -- |
Genfit SA | -- |
Cellectis SA | -313.5% |
Adaptimmune Therapeutics PLC | 54.22% |
Akari Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -35.04% |
Return on Assets | -21.80% |
Return on Invested Capital | -32.51% |
Gross Profit Margin (Quarterly) | 37.48% |
Operating Margin (Quarterly) | -38.93% |
Return on Net Operating Assets | -43.67% |